However, the seven-time world champion does still faces a Court of Arbitration for Sport (CAS) hearing after an appeal was launched by the International Ski Federation (FIS).

Johaug tested positive for anabolic steroid clostebol while training in Italy last September. 

She claimed to have used the substance inadvertently via a sun cream wrongly given to her by a team doctor.

Anti-Doping Norway argued she should be blamed for "not having undertaken further investigation of the drug she received and used", which reportedly came in a package marked with the word "doping".

They recommended a 14 month suspension before this was reduced by a further month in the eventual Norwegian Olympic and Paralympic Committee and Confederation of Sports’ (NIF) verdict.

FIS described this as "on the low end of the range of reasonable sanctions" when filing their appeal earlier this month.

insidethegames has been told that they believe a four-year ban would have been more appropriate.

WADA have not announced why they opted against a similar appeal.

"WADA can today confirm [with regards to the Therese Johaug case] that it will not be lodging an appeal to the CAS," a spokesperson told insidethegames. 

"We will make no further comment at this time."

The backdated nature of Johaug's ban means she will be free to compete at the Pyeongchang 2018 Winter Olympic Games. 

The NIF Adjudication Committee confirmed last month that Johaug's suspension will be backdated to October 2016.

As it stands, she will therefore be able to return to competition in November 2017, around the same time as the start of the next season.

A provisional suspension which was originally due to expire on December 18 was extended to February 19 of this year meaning Johaug, the reigning World Cup champion, has not competed this season.

Johaug, a member of Norway's winning 4x5 kilometres relay team at the 2010 Winter Olympics in Vancouver, is a huge star in her home country. 

She has previously claimed that she finds it "very strange" that people do not believe her reasoning for the failed test.

CAS has not yet confirmed a date for the FIS appeal hearing.

"A CAS arbitration procedure is in progress," they said earlier this month.

"First, the parties will exchange written submissions and a panel composed of either one or three arbitrators will be constituted.

"The panel will then issue directions with respect to the holding of a hearing.

"Following the hearing, the panel will deliberate and, at a later date, issue a decision in the form of an arbitral award."